$INCY
INCYTE CORP Stock $incy

$incy Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000087916924000149 Filed on July 30, 2024

Income Statement

Concept	2024 Q3	2024 Q2
Revenue	$1.138B	$1.044B
YoY Change	23.81%	9.34%
Cost Of Revenue	$85.99M	$76.63M
YoY Change	43.1%	22.37%
Gross Profit	$1.052B	$967.1M
YoY Change	22.46%	8.42%
Gross Profit Margin	92.44%	92.66%
Selling, General & Admin	$309.2M	$306.0M
YoY Change	15.42%	7.77%
% of Gross Profit	29.4%	31.64%
Research & Development	$573.2M	$1.138B
YoY Change	52.56%	184.06%
% of Gross Profit	54.49%	117.71%
Depreciation & Amortization	$22.52M	$5.384M
YoY Change	5.23%	-73.47%
% of Gross Profit	2.14%	0.56%
Operating Expenses	$882.4M	$1.444B
YoY Change	37.1%	109.21%
Operating Profit	$146.1M	-$478.1M
YoY Change	-31.96%	-337.16%
Interest Expense	-$13.76M	$38.58M
YoY Change	-2308.03%	-6.25%
% of Operating Profit	-9.42%
Other Income/Expense, Net	$24.20M	$49.77M
YoY Change	-47.82%	16.64%
Pretax Income	$156.5M	-$389.8M
YoY Change	-33.05%	-240.41%
Income Tax	$50.07M	$54.82M
% Of Pretax Income	31.99%
Net Earnings	$106.5M	-$444.6M
YoY Change	-37.84%	-318.43%
Net Earnings / Revenue	9.36%	-42.6%
Basic Earnings Per Share	$0.55	-$2.04
Diluted Earnings Per Share	$0.54	-$2.04
COMMON SHARES
Basic Shares Outstanding	192.6M shares	224.5M shares
Diluted Shares Outstanding	195.8M shares	218.2M shares

Balance Sheet

Concept	2024 Q3	2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.771B	$1.450B
YoY Change	-49.63%	-57.66%
Cash & Equivalents	$1.304B	$987.3M
Short-Term Investments	$467.2M	$462.2M
Other Short-Term Assets	$205.1M	$208.0M
YoY Change	19.47%	24.42%
Inventory	$70.40M	$100.7M
Prepaid Expenses
Receivables	$758.5M	$739.1M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$2.809B	$2.567B
YoY Change	-36.2%	-39.8%
LONG-TERM ASSETS
Property, Plant & Equipment	$773.1M	$762.0M
YoY Change	5.46%	-1.67%
Goodwill	$155.6M	$155.6M
YoY Change	0.0%	0.0%
Intangibles
YoY Change
Long-Term Investments	$27.57M	$99.54M
YoY Change	-82.07%	-41.55%
Other Assets	$40.38M	$21.92M
YoY Change	-50.12%	-96.9%
Total Long-Term Assets	$2.204B	$2.095B
YoY Change	10.99%	7.76%
TOTAL ASSETS
Total Short-Term Assets	$2.809B	$2.567B
Total Long-Term Assets	$2.204B	$2.095B
Total Assets	$5.012B	$4.662B
YoY Change	-21.54%	-24.91%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$178.7M	$148.2M
YoY Change	28.19%	-4.73%
Accrued Expenses	$1.128B	$1.034B
YoY Change	37.45%	69.06%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$3.932M	$32.62M
YoY Change	26.84%	930.29%
Total Short-Term Liabilities	$1.502B	$1.337B
YoY Change	33.52%	19.51%
LONG-TERM LIABILITIES
Long-Term Debt	$28.22M	$28.75M
YoY Change	-2.34%	-2.53%
Other Long-Term Liabilities	$144.7M	$142.1M
YoY Change	8.72%	-55.5%
Total Long-Term Liabilities	$144.7M	$142.1M
YoY Change	8.72%	-59.26%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.502B	$1.337B
Total Long-Term Liabilities	$144.7M	$142.1M
Total Liabilities	$1.841B	$1.665B
YoY Change	26.39%	13.44%
SHAREHOLDERS EQUITY
Retained Earnings	-$1.274B	-$1.380B
YoY Change	3030.91%	551.27%
Common Stock	$4.430B	$4.383B
YoY Change	-10.5%	-11.02%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$3.171B	$2.997B
YoY Change
Total Liabilities & Shareholders Equity	$5.012B	$4.662B
YoY Change	-21.54%	-24.91%

Cashflow Statement

Concept	2024 Q3	2024 Q2
OPERATING ACTIVITIES
Net Income	$106.5M	-$444.6M
YoY Change	-37.84%	-318.43%
Depreciation, Depletion And Amortization	$22.52M	$5.384M
YoY Change	5.23%	-73.47%
Cash From Operating Activities	$310.9M	-$575.6M
YoY Change	110.19%	-287.77%
INVESTING ACTIVITIES
Capital Expenditures	$5.187M	$48.70M
YoY Change	-52.85%	563.76%
Acquisitions
YoY Change
Other Investing Activities	$43.46M	$268.0M
YoY Change	-789.86%	-291364.13%
Cash From Investing Activities	$38.27M	$213.8M
YoY Change	-322.52%	-2978.18%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-32.35M	-1.997B
YoY Change	-13.27%	-15620.49%
NET CHANGE
Cash From Operating Activities	310.9M	-575.6M
Cash From Investing Activities	38.27M	213.8M
Cash From Financing Activities	-32.35M	-1.997B
Net Change In Cash	316.8M	-2.359B
YoY Change	239.18%	-856.15%
FREE CASH FLOW
Cash From Operating Activities	$310.9M	-$575.6M
Capital Expenditures	$5.187M	$48.70M
Free Cash Flow	$305.7M	-$624.3M
YoY Change	123.29%	-308.65%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	191572449	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	191572449	shares
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	4370119000	usd
CY2023Q1	us-gaap	Stock Issued During Period Shares Share Based Compensation StockIssuedDuringPeriodSharesShareBasedCompensation	313995	shares
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	11235000	usd
CY2023Q1	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	1073	shares
CY2023Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	80000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	53558000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	5873000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	21703000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	4462568000	usd
CY2023Q2	us-gaap	Stock Issued During Period Shares Share Based Compensation StockIssuedDuringPeriodSharesShareBasedCompensation	59093	shares
CY2023Q2	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	216168	shares
CY2023Q2	incy	Stock Issued During Period Value Stock Options And Restricted Stock Units Exercised And Employee Stock Purchase Plan StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockUnitsExercisedAndEmployeeStockPurchasePlan	13704000	usd
CY2023Q2	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	1282	shares
CY2023Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	80000	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	54928000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	5864000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	203548000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	4740692000	usd
	us-gaap	Profit Loss ProfitLoss	-275053000	usd
	us-gaap	Profit Loss ProfitLoss	225251000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	43995000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	39508000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	116418000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	107899000	usd
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	51733000	usd
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	61864000	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-2588000	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	3670000	usd
	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	139188000	usd
	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	36493000	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	437000	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	14570000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-4507000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-6885000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	39748000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	8219000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	84976000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	53436000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	38573000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-122008000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	27428000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	92500000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-356752000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	200923000	usd
	us-gaap	Proceeds From Sale Of Longterm Investments ProceedsFromSaleOfLongtermInvestments	227257000	usd
	us-gaap	Proceeds From Sale Of Longterm Investments ProceedsFromSaleOfLongtermInvestments	45000	usd
	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	63692000	usd
	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	19243000	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	15000000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	140708000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	2004687000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	usd
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	14960000	usd
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	28367000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	6865000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	3428000	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	1782000	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	1638000	usd
	incy	Payment Of Contingent Consideration PaymentOfContingentConsideration	11216000	usd
	incy	Payment Of Contingent Consideration PaymentOfContingentConsideration	6424000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2009590000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	16877000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-663000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-2090000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2226297000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	179722000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3215221000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2953120000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	988924000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3132842000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	229674000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	137313000	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	800000	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	4420000	usd
	incy	Excise Tax On Repurchase Of Common Stock Incurred But Not Yet Paid ExciseTaxOnRepurchaseOfCommonStockIncurredButNotYetPaid	19185000	usd
	incy	Excise Tax On Repurchase Of Common Stock Incurred But Not Yet Paid ExciseTaxOnRepurchaseOfCommonStockIncurredButNotYetPaid	0	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	2188000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	5275000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	1468000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	1024000	usd
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.</span></div>
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1043759000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	954610000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1924648000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1763283000	usd
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2024Q2	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	24579000	usd
CY2023Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	23282000	usd
CY2024Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	284706000	usd
CY2023Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	209793000	usd
CY2024Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	46687000	usd
CY2023Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	36862000	usd
CY2024Q2	incy	Inventory Net Current And Noncurrent InventoryNetCurrentAndNoncurrent	355972000	usd
CY2023Q4	incy	Inventory Net Current And Noncurrent InventoryNetCurrentAndNoncurrent	269937000	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	100700000	usd
CY2024Q2	us-gaap	Inventory Noncurrent InventoryNoncurrent	255300000	usd
CY2024Q2	incy	Inventory Recorded As Research And Development Expense InventoryRecordedAsResearchAndDevelopmentExpense	34900000	usd
CY2024Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1059533000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1021447000	usd
CY2024Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	297524000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	269934000	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	762009000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	751513000	usd
CY2024Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	48700000	usd
CY2024Q2	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	444305000	usd
CY2023Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	387362000	usd
CY2024Q2	incy	Accrued Clinical Related Costs Current AccruedClinicalRelatedCostsCurrent	105675000	usd
CY2023Q4	incy	Accrued Clinical Related Costs Current AccruedClinicalRelatedCostsCurrent	109618000	usd
CY2024Q2	us-gaap	Provision For Loss On Contracts ProvisionForLossOnContracts	349904000	usd
CY2023Q4	us-gaap	Provision For Loss On Contracts ProvisionForLossOnContracts	279914000	usd
CY2024Q2	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	39541000	usd
CY2023Q4	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	37369000	usd
CY2024Q2	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	32396000	usd
CY2023Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	42295000	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	4929000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	5686000	usd
CY2024Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	57566000	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	73325000	usd
CY2024Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1034316000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	935569000	usd
CY2024Q2	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	33325849	shares
CY2024Q2	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	60.00
CY2024Q2	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	2000000000.0	usd
CY2024Q2	incy	Share Repurchase Fees And Expenses ShareRepurchaseFeesAndExpenses	24300000	usd
CY2024Q2	us-gaap	Share Repurchase Program Excise Tax ShareRepurchaseProgramExciseTax	19200000	usd
CY2024Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	56600000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	116400000	usd
CY2023Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	54500000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	107900000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	7165342	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue	72.17
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	7080132	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue	71.11
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	10815026	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized	1000000	shares
	incy	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesGranted	1560390	shares
	incy	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Canceled ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesCanceled	443403	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	10698039	shares
	incy	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Annualized Forfeiture Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedAnnualizedForfeitureRate	0.05
CY2024Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-389777000	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	277604000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-153618000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	329460000	usd
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	54824000	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	74056000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	121435000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	104209000	usd
CY2024Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.141
CY2023Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.267
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.790
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.316
	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	19300000	usd
	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	7500000	usd
	us-gaap	Unrecognized Tax Benefits Increases Resulting From Acquisition UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition	8800000	usd
	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	3000000.0	usd
CY2024Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-444601000	usd
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	203548000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-275053000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	225251000	usd
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	218175000	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	223248000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	221329000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	223104000	shares
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.04
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.91
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.24
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.01
CY2024Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-444601000	usd
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	203548000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-275053000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	225251000	usd
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	218175000	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	223248000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	221329000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	223104000	shares
CY2024Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2023Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	2401000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	2437000	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	218175000	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	225649000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	221329000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	225541000	shares
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.04
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.90
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.24
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.00
CY2024Q2	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	5200000	usd
	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	10600000	usd
CY2023Q2	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	4000000.0	usd
	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	9600000	usd
CY2024Q2	us-gaap	Defined Benefit Plan Service Cost DefinedBenefitPlanServiceCost	2657000	usd
CY2023Q2	us-gaap	Defined Benefit Plan Service Cost DefinedBenefitPlanServiceCost	1733000	usd
	us-gaap	Defined Benefit Plan Service Cost DefinedBenefitPlanServiceCost	5278000	usd
	us-gaap	Defined Benefit Plan Service Cost DefinedBenefitPlanServiceCost	3821000	usd
CY2024Q2	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	786000	usd
CY2023Q2	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	44000	usd
	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	1227000	usd
	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	661000	usd
CY2024Q2	us-gaap	Defined Benefit Plan Expected Return On Plan Assets DefinedBenefitPlanExpectedReturnOnPlanAssets	1961000	usd
CY2023Q2	us-gaap	Defined Benefit Plan Expected Return On Plan Assets DefinedBenefitPlanExpectedReturnOnPlanAssets	736000	usd
	us-gaap	Defined Benefit Plan Expected Return On Plan Assets DefinedBenefitPlanExpectedReturnOnPlanAssets	3444000	usd
	us-gaap	Defined Benefit Plan Expected Return On Plan Assets DefinedBenefitPlanExpectedReturnOnPlanAssets	2276000	usd
CY2024Q2	us-gaap	Defined Benefit Plan Amortization Of Prior Service Cost Credit DefinedBenefitPlanAmortizationOfPriorServiceCostCredit	206000	usd
CY2023Q2	us-gaap	Defined Benefit Plan Amortization Of Prior Service Cost Credit DefinedBenefitPlanAmortizationOfPriorServiceCostCredit	276000	usd
	us-gaap	Defined Benefit Plan Amortization Of Prior Service Cost Credit DefinedBenefitPlanAmortizationOfPriorServiceCostCredit	407000	usd
	us-gaap	Defined Benefit Plan Amortization Of Prior Service Cost Credit DefinedBenefitPlanAmortizationOfPriorServiceCostCredit	379000	usd
CY2024Q2	us-gaap	Defined Benefit Plan Actuarial Gain Loss DefinedBenefitPlanActuarialGainLoss	-393000	usd
CY2023Q2	us-gaap	Defined Benefit Plan Actuarial Gain Loss DefinedBenefitPlanActuarialGainLoss	90000	usd
	us-gaap	Defined Benefit Plan Actuarial Gain Loss DefinedBenefitPlanActuarialGainLoss	-480000	usd
	us-gaap	Defined Benefit Plan Actuarial Gain Loss DefinedBenefitPlanActuarialGainLoss	0	usd
CY2024Q2	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	2081000	usd
CY2023Q2	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	1227000	usd
	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	3948000	usd
	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	2585000	usd
CY2024Q2	us-gaap	Defined Benefit Plan Expected Future Employer Contributions Current Fiscal Year DefinedBenefitPlanExpectedFutureEmployerContributionsCurrentFiscalYear	10000000.0	usd
CY2024Q2	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0000879169-24-000149-index-headers.html	Edgar Link	pending
0000879169-24-000149-index.html	Edgar Link	pending
0000879169-24-000149.txt	Edgar Link	pending
0000879169-24-000149-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
incy-20240630.htm	Edgar Link	pending
incy-20240630.xsd	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
incy-20240630_cal.xml	Edgar Link	unprocessable
incy-20240630_def.xml	Edgar Link	unprocessable
incy-6302024xex311.htm	Edgar Link	pending
incy-6302024xex312.htm	Edgar Link	pending
incy-6302024xex321.htm	Edgar Link	pending
incy-6302024xex322.htm	Edgar Link	pending
incytecorporationexhibit101.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
incy-20240630_lab.xml	Edgar Link	unprocessable
incy-20240630_pre.xml	Edgar Link	unprocessable
incy-20240630_htm.xml	Edgar Link	completed
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$INCY
INCYTE CORP Stock $incy

2024 Q3 Form 10-Q Financial Statement

#000087916924000149 Filed on July 30, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$INCY INCYTE CORP Stock $incy

2024 Q3 Form 10-Q Financial Statement

#000087916924000149 Filed on July 30, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$INCY
INCYTE CORP Stock $incy